Quantcast

Latest Prostate-specific antigen Stories

2014-07-11 09:19:30

Harvard School of Public Health Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health (HSPH). The researchers found that the association remained even among men who received regular PSA screening, suggesting the increased risk of lethal cancer cannot be explained by diagnostic bias. It is the largest and most comprehensive study to date to look at the...

2014-06-11 08:31:25

LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Diagnostic Testing World Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cancer_diagnostic_testing_world_markets.html Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs...

2014-05-27 23:03:55

Humility of Mary Health Partners will provide free PSA blood draws to check 100 men for prostate cancer during the Fuel the Fight car and motorcycle show June 1 at Boardman High School. Youngstown, Ohio (PRWEB) May 27, 2014 Humility of Mary Health Partners will provide 100 free PSA blood draws to check for prostate cancer during the Fuel the Fight car and motorcycle show June 1 in Boardman. Fuel the Fight, sponsored by the HMHP Foundation and Sweeney Chevrolet, Buick, GMC, benefits Man Up...

2014-05-27 08:27:46

-- High calibre German consulting company appointed to assist CE Mark registration process SYDNEY, May 27, 2014 /PRNewswire/ -- Australian biotechnology company Minomic International Limited will register its MiStat(TM) ELISA prostate cancer test for CE Mark approval in the latter part of 2014. Achieving CE approval will be a key commercial milestone for the company, allowing it to sell and market its early detection diagnostic technology in the 33 member countries within the...

2014-05-17 12:20:17

Panel discusses long-term effect on quality of life ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- A series of studies evaluating the outcomes, benefits, concerns and quality of life of men undergoing active surveillance for prostate cancer will be presented to media at a special press conference during the 2014 Annual Scientific Meeting of the American Urological Association (AUA). Stacy Loeb, MD, assistant professor at New York University, New York, NY, will moderate the session,...

2014-04-24 08:34:08

Beckman Coulter's Prostate Health Index (phi) Available Nationwide for Better Prostate Cancer Detection BREA, Calif., April 24, 2014 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in prostate cancer diagnostics, announces national availability of the Prostate Health Index (phi)*, a simple, non-invasive blood test that is three times more specific in detecting prostate cancer(1) than PSA (prostate-specific antigen). The new test's accuracy decreases the need for many men...

2014-04-18 13:44:32

The presence of chronic inflammation in benign prostate tissue was associated with high-grade, or aggressive, prostate cancer, and this association was found even in those with low prostate-specific antigen (PSA) levels, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. An analysis of prostate tissue biopsies collected from some participants of the placebo arm of the Prostate Cancer Prevention...

2014-04-15 08:28:19

Phase III Trial Now Recruiting Patients SANTA ROSA, Calif., April 15, 2014 /PRNewswire/ -- A phase III clinical trial conducted at the Meir Medical Center in Kfar-Saba, Israel is now recruiting participants to study the effects of dietary supplement PectaSol-C® modified citrus pectin (MCP) in controlling prostate specific antigen (PSA) levels in prostate cancer patients. "MCP has shown activity against prostate and other cancers in a number of previous studies, and toxicology...

2014-04-08 12:30:37

-- Peak US urology organisation CUSP Group, LLC to evaluate MiStat(TM) technology SYDNEY, April 8, 2014 /PRNewswire/ -- Private Australian biotechnology company Minomic International Ltd will launch two overseas trials of its MiStat(TM) prostate cancer screening test, following an agreement with the prestigious CUSP Group, LLC a Uro-Oncology Trials Management Organisation in the United States. An initial pilot study to be launched in April will examine 300 patient samples and is...

2014-04-07 08:31:25

HOUSTON, April 7, 2014 /PRNewswire/ -- C4 Imaging LLC is pleased to announce the first patient implant with Sirius(TM), its novel positive-signal MRI Marker. Sirius(TM) is used following treatment of prostate cancer with brachytherapy to facilitate seed localization within the prostate, utilizing a single post-implant Magnetic Resonance (MR) imaging procedure. The first implant was performed at The University of Texas MD Anderson Cancer Center (Houston, Texas) and was used during a procedure...


Word of the Day
penuche
  • A fudgelike confection of brown sugar, cream or milk, and chopped nuts.
'Penuche' is a variant of 'panocha,' a coarse grade of sugar made in Mexico. 'Panocha' probably comes from the Spanish 'panoja, panocha,' ear of grain.
Related